25-Hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1017-1023

  Heine, Guido ^a   Tabeling, Christoph ^a   Hartmann, Bjoern ^b   Calera, Carla R González ^a   Kühl, Anja A ^a   Lindner, Juliane ^a   Radbruch, Andreas ^c   Witzenrath, Martin ^a   Worm, Margitta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CALCIFEDIOL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; OVALBUMIN;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESENSITIZATION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; TH2 CELL; VITAMIN D DEFICIENCY;

ANIMALS; CALCIFEDIOL; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG THERAPY, COMBINATION; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INFLAMMATION; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TIME FACTORS;

EID: 84906090955     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301656     Document Type: Article

References (45)

1. Mora, J. R., M. Iwata, and U. H. von Andrian. 2008. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 8: 685-698.
2. Heine, G., K. Anton, B. M. Henz, and M. Worm. 2002. 1alpha,25- dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur. J. Immunol. 32: 3395-3404.
3. Milovanovic, M., G. Heine, W. Hallatschek, B. Opitz, A. Radbruch, and M. Worm. 2010. Vitamin D receptor binds to the epsilon germline gene promoter and exhibits transrepressive activity. J. Allergy Clin. Immunol. 126: 1016-1023, 1023 e1011-1014.
4. Heine, G., U. Niesner, H. D. Chang, A. Steinmeyer, U. Zügel, T. Zuberbier, A. Radbruch, and M. Worm. 2008. 1,25-Dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 38: 2210-2218.
5. Hartmann, B., G. Heine, M. Babina, A. Steinmeyer, U. Zügel, A. Radbruch, and M. Worm. 2011. Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. Allergy 66: 540-548.
6. Xystrakis, E., S. Kusumakar, S. Boswell, E. Peek, Z. Urry, D. F. Richards, T. Adikibi, C. Pridgeon, M. Dallman, T. K. Loke, et al. 2006. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoidresistant asthma patients. J. Clin. Invest. 116: 146-155.
7. Sigmundsdottir, H., J. Pan, G. F. Debes, C. Alt, A. Habtezion, D. Soler, and E. C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8: 285-293.
8. Kreutz, M., R. Andreesen, S. W. Krause, A. Szabo, E. Ritz, and H. Reichel. 1993. 1,25-Dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82: 1300-1307.
9. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
10. Hyppönen, E., D. J. Berry, M.Wjst, and C. Power. 2009. Serum 25-hydroxyvitamin D and IgE- A significant but nonlinear relationship. Allergy 64: 613-620.
11. Zittermann, A., J. Dembinski, and P. Stehle. 2004. Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr. Allergy Immunol. 15: 242-246.
12. Searing, D. A., Y. Zhang, J. R. Murphy, P. J. Hauk, E. Goleva, and D. Y. Leung. 2010. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J. Allergy Clin. Immunol. 125: 995-1000.
13. Brehm, J. M., J. C. Celedón, M. E. Soto-Quiros, L. Avila, G. M. Hunninghake, E. Forno, D. Laskey, J. S. Sylvia, B. W. Hollis, S. T. Weiss, and A. A. Litonjua. 2009. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am. J. Respir. Crit. Care Med. 179: 765-771.
14. Brehm, J. M., B. Schuemann, A. L. Fuhlbrigge, B. W. Hollis, R. C. Strunk, R. S. Zeiger, S. T. Weiss, and A. A. Litonjua. 2010. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 126: 52-58 e55.
15. Larché, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
16. Frew, A. J. 2010. Allergen immunotherapy. J. Allergy Clin. Immunol. 125(2 Suppl. 2)S306-S313.
17. Akdis, C. A., T. Blesken, M. Akdis, B. Wüthrich, and K. Blaser. 1998. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102: 98-106.
18. Scadding, G. W., M. H. Shamji, M. R. Jacobson, D. I. Lee, D. Wilson, M. T. Lima, L. Pitkin, C. Pilette, K. Nouri-Aria, and S. R. Durham. 2010. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin Efacilitated allergen binding to B cells. Clin. Exp. Allergy 40: 598-606.
19. Taher, Y. A., B. C. van Esch, G. A. Hofman, P. A. Henricks, and A. J. van Oosterhout. 2008. 1a,25-Dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-b. J. Immunol. 180: 5211-5221.
20. Holick, M. F. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266-281.
21. Heine, G., A. Dahten, K. Hilt, D. Ernst, M. Milovanovic, B. Hartmann, and M. Worm. 2009. Liver X receptors control IgE expression in B cells. J. Immunol. 182: 5276-5282.
22. Luger, E. O., V. Fokuhl, M. Wegmann, M. Abram, K. Tillack, G. Achatz, R. A. Manz, M. Worm, A. Radbruch, and H. Renz. 2009. Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. J. Allergy Clin. Immunol. 124: 819-826 e814.
23. Weise, C., Y. Zhu, D. Ernst, A. A. Kühl, and M. Worm. 2011. Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. Exp. Dermatol. 20: 805-809.
24. Witzenrath, M., B. Ahrens, S. M. Kube, A. Braun, H. G. Hoymann, A. C. Hocke, S. Rosseau, N. Suttorp, E. Hamelmann, and H. Schütte. 2006. Detection of allergen-induced airway hyperresponsiveness in isolated mouse lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L466-L472.
25. Witzenrath, M., B. Ahrens, S. M. Kube, A. C. Hocke, S. Rosseau, E. Hamelmann, N. Suttorp, and H. Schütte. 2006. Allergic lung inflammation induces pulmonary vascular hyperresponsiveness. Eur. Respir. J. 28: 370-377.
26. Held, H. D., C. Martin, and S. Uhlig. 1999. Characterization of airway and vascular responses in murine lungs. Br. J. Pharmacol. 126: 1191-1199.
27. Haberberger, R. V., C. Tabeling, S. Runciman, B. Gutbier, P. Konig, M. Andratsch, H. Schutte, N. Suttorp, I. Gibbins, and M. Witzenrath. 2009. Role of sphingosine kinase 1 in allergen-induced pulmonary vascular remodeling and hyperresponsiveness. J. Allergy Clin. Immunol. 124: 933-941 e931-939.
28. Mawer, E. B., J. Backhouse, C. A. Holman, G. A. Lumb, and S. W. Stanbury. 1972. The distribution and storage of vitamin D and its metabolites in human tissues. Clin. Sci. 43: 413-431.
29. Heine, G., A. Lahl, C. Müller, and M. Worm. 2010. Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. Br. J. Dermatol. 163: 863-865.
30. Lou, Y. R., F. Molnár, M. Peräkylä, S. Qiao, A. V. Kalueff, R. St-Arnaud, C. Carlberg, and P. Tuohimaa. 2010. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J. Steroid Biochem. Mol. Biol. 118: 162-170.
31. Rowling, M. J., C. Gliniak, J. Welsh, and J. C. Fleet. 2007. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J. Nutr. 137: 2608-2615.
32. Deluca, H. F., J. M. Prahl, and L. A. Plum. 2011. 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch. Biochem. Biophys. 505: 226-230.
33. Wittke, A., V. Weaver, B. D. Mahon, A. August, and M. T. Cantorna. 2004. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 173: 3432-3436.
34. Radbruch, A., G. Muehlinghaus, E. O. Luger, A. Inamine, K. G. Smith, T. Dörner, and F. Hiepe. 2006. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6: 741-750.
35. Vanhooke, J. L., J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. DeLuca. 2006. CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin. Proc. Natl. Acad. Sci. USA 103: 75-80.
36. Grundström, J., T. Neimert-Andersson, C. Kemi, O. B. Nilsson, T. Saarne, M. Andersson, M. van Hage, and G. Gafvelin. 2012. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergenspecific immunotherapy in a mouse model for cat allergy. Int. Arch. Allergy Immunol. 157: 136-146.
37. Agrawal, T., G. K. Gupta, and D. K. Agrawal. 2013. Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin. Exp. Allergy 43: 672-683.
38. Grünig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
39. Mahon, B. D., A. Wittke, V. Weaver, and M. T. Cantorna. 2003. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 89: 922-932.
40. Barrat, F. J., D. J. Cua, A. Boonstra, D. F. Richards, C. Crain, H. F. Savelkoul, R. de Waal-Malefyt, R. L. Coffman, C. M. Hawrylowicz, and A. O'Garra. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
41. Daniel, C., N. A. Sartory, N. Zahn, H. H. Radeke, and J. M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324: 23-33.
42. Schulze, T., S. Golfier, C. Tabeling, K. Rabel, M. H. Graler, M. Witzenrath, and M. Lipp. 2011. Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J. 25: 4024-4036.
43. Green, F. H., J. C. Butt, A. L. James, and N. G. Carroll. 2006. Abnormalities of the bronchial arteries in asthma. Chest 130: 1025-1033.
44. Holick, M. F. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80 (Suppl 6.)1678S-1688S.
45. Hintzpeter, B., G. B. Mensink, W. Thierfelder, M. J. Müller, and C. Scheidt-Nave. 2008. Vitamin D status and health correlates among German adults. Eur. J. Clin. Nutr. 62: 1079-1089.